Similar articles for PMID: 18214050

Year	Number of Results
1996	3
1997	2
1998	4
1999	5
2000	13
2001	13
2002	14
2003	14
2004	9
2005	15
2006	13
2007	20
2008	20
2009	11
2010	9
2011	8
2012	8
2013	10
2014	6
2015	6
2016	4
2017	3
2018	3
2019	2
2020	2
2021	2
2022	3
2023	6
2024	3
2025	0

1

Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.

Kosmidis P, Fountzilas G, Baka S, Samantas E, Dimopoulos AM, Gogas H, Skarlos D, Papacostas P, Boukovinas J, Bakogiannis Ch, Pantelakos P, Athanasiou H, Misailidou D, Tsekeris P, Pavlidis N. Kosmidis P, et al. Anticancer Res. 2007 Nov-Dec;27(6C):4391-5. Anticancer Res. 2007. PMID: 18214050 Free article. Clinical Trial.

2

Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS. Lee DH, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1037-44. doi: 10.1016/j.ijrobp.2005.04.034. Epub 2005 Jul 18. Int J Radiat Oncol Biol Phys. 2005. PMID: 16024178 Clinical Trial.

3

A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).

Schallier D, Neyns B, Fontaine C, Steene JV, De Mey J, Meysman M, De Grève J. Schallier D, et al. Lung Cancer. 2007 May;56(2):247-54. doi: 10.1016/j.lungcan.2006.12.017. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337086 Clinical Trial.

4

A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.

Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G. Argiris A, et al. Lung Cancer. 2004 Aug;45(2):243-53. doi: 10.1016/j.lungcan.2004.02.008. Lung Cancer. 2004. PMID: 15246197 Clinical Trial.

5

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

Zwitter M, Kovac V, Smrdel U, Strojan P. Zwitter M, et al. J Thorac Oncol. 2006 Sep;1(7):662-6. J Thorac Oncol. 2006. PMID: 17409933 Free article. Clinical Trial.

6

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP. Kosmas C, et al. Cancer. 2001 Dec 1;92(11):2902-10. doi: 10.1002/1097-0142(20011201)92:11<2902::aid-cncr10103>3.0.co;2-o. Cancer. 2001. PMID: 11753965 Clinical Trial.

7

Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).

Schallier D, Bral S, Ilsen B, Neyns B, Fontaine C, Decoster L, De Mey J, Meysman M, De Grève J. Schallier D, et al. J Thorac Oncol. 2009 Jun;4(6):728-35. doi: 10.1097/JTO.0b013e3181a4ec14. J Thorac Oncol. 2009. PMID: 19404217 Free article.

8

Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.

Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L. Hirsh V, et al. J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92. J Thorac Oncol. 2007. PMID: 17909355 Free article. Clinical Trial.

9

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.

Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K. Isokangas OP, et al. Ann Oncol. 1999 Sep;10(9):1059-63. doi: 10.1023/a:1008305017829. Ann Oncol. 1999. PMID: 10572603 Free article. Clinical Trial.

10

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Bradley JD, et al. Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601342 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 18214050

208 results

Results by year